1. Home
  2. BOLT vs IINN Comparison

BOLT vs IINN Comparison

Compare BOLT & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • IINN
  • Stock Information
  • Founded
  • BOLT 2015
  • IINN 2018
  • Country
  • BOLT United States
  • IINN Israel
  • Employees
  • BOLT N/A
  • IINN N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • IINN Medical/Dental Instruments
  • Sector
  • BOLT Health Care
  • IINN Health Care
  • Exchange
  • BOLT Nasdaq
  • IINN Nasdaq
  • Market Cap
  • BOLT 22.6M
  • IINN 23.8M
  • IPO Year
  • BOLT 2021
  • IINN 2021
  • Fundamental
  • Price
  • BOLT $0.49
  • IINN $0.85
  • Analyst Decision
  • BOLT Hold
  • IINN
  • Analyst Count
  • BOLT 5
  • IINN 0
  • Target Price
  • BOLT $1.25
  • IINN N/A
  • AVG Volume (30 Days)
  • BOLT 136.2K
  • IINN 1.8M
  • Earning Date
  • BOLT 03-20-2025
  • IINN 03-24-2025
  • Dividend Yield
  • BOLT N/A
  • IINN N/A
  • EPS Growth
  • BOLT N/A
  • IINN N/A
  • EPS
  • BOLT N/A
  • IINN N/A
  • Revenue
  • BOLT $9,779,000.00
  • IINN N/A
  • Revenue This Year
  • BOLT $9.87
  • IINN N/A
  • Revenue Next Year
  • BOLT N/A
  • IINN N/A
  • P/E Ratio
  • BOLT N/A
  • IINN N/A
  • Revenue Growth
  • BOLT 35.86
  • IINN N/A
  • 52 Week Low
  • BOLT $0.46
  • IINN $0.80
  • 52 Week High
  • BOLT $1.56
  • IINN $2.45
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 44.93
  • IINN 27.42
  • Support Level
  • BOLT $0.49
  • IINN $1.00
  • Resistance Level
  • BOLT $0.52
  • IINN $1.11
  • Average True Range (ATR)
  • BOLT 0.03
  • IINN 0.08
  • MACD
  • BOLT -0.00
  • IINN -0.01
  • Stochastic Oscillator
  • BOLT 24.24
  • IINN 9.33

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About IINN Inspira Technologies Oxy B.H.N. Ltd.

Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Share on Social Networks: